Kenneth E. Rosenzweig
Papers
1
Total Citations
9
H-Index
1
About
Kenneth E. Rosenzweig is a leading thoracic radiation oncologist whose research focuses on optimizing treatment for early-stage lung cancer, particularly for patients who cannot undergo traditional lobectomy. His work centers on patient-centered outcomes, comparing the efficacy and quality-of-life impacts of sublobar resection versus stereotactic body radiation therapy (SBRT). In his highly cited 2024 study, Rosenzweig provided critical longitudinal data on quality of life following these two treatments, addressing a significant gap in the literature. This research has garnered 9 citations, reflecting its immediate relevance to clinical decision-making. By prioritizing patient-reported outcomes, Rosenzweig has helped shift the paradigm toward more personalized, less invasive approaches for vulnerable populations. His contributions are instrumental in guiding oncologists and patients through the complex trade-offs between surgical and radiotherapeutic options, ensuring that treatment selection considers not just survival but also the lived experience of recovery and long-term well-being.
Research Focus
Key Achievements
Top Papers
- 1